Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$20.19 – $24.00
79% from low
Sector
Asset Management - Global
Exchange
ARCX
ETF
The Columbia Research Enhanced International Equity ETF (REFA) dedicates a minimum of 80% of its total assets, including any capital acquired through borrowing, to investments in equity securities. These holdings comprise a variety of instruments, such as ordinary shares traded on local exchanges, American Depositary Receipts (ADRs), and Global Depositary Receipts (GDRs), all issued by companies based in developed international economies. The fund's underlying index is derived from a specific, narrower selection of companies chosen from a broader initial investment universe. It is important to note that this fund operates on a non-diversified basis.
www.columbiathreadneedleus.comNo one on the platform currently holds REFA.
No tracked institution reports a position in REFA as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-18 | $0.0068 | 2025-12-26 |
No one on the platform has traded REFA yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
The Columbia Research Enhanced International Equity ETF (REFA) dedicates a minimum of 80% of its total assets, including any capital acquired through borrowing, to investments in equity securities. These holdings comprise a variety of instruments, such as ordinary shares traded on local exchanges, American Depositary Receipts (ADRs), and Global Depositary Receipts (GDRs), all issued by companies based in developed international economies. The fund's underlying index is derived from a specific, narrower selection of companies chosen from a broader initial investment universe. It is important to note that this fund operates on a non-diversified basis.
Top constituents
top 25 · 43% of the fund